10X GENOMICS, INC. (TXG): Price and Financial Metrics
10X GENOMICS, INC. (TXG)
Today's Latest Price: $149.04 USD
Updated Dec 4 4:00pm
Add TXG to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 70 in Medical - Services
See all "A" rated Strong Buy stocks
TXG Stock Summary
- With a one year PEG ratio of 0.47, 10x Genomics Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 6.11% of US stocks.
- TXG's went public 1.23 years ago, making it older than just 1.32% of listed US stocks we're tracking.
- TXG's price/sales ratio is 59.49; that's higher than the P/S ratio of 95.91% of US stocks.
- Stocks that are quantitatively similar to TXG, based on their financial statements, market capitalization, and price volatility, are ESTC, WIX, GWPH, PEGA, and SMAR.
- TXG's SEC filings can be seen here. And to visit 10x Genomics Inc's official web site, go to www.10xgenomics.com.
TXG Stock Price Chart Interactive Chart >
TXG Price/Volume Stats
| Current price | $149.04 | 52-week high | $166.31 |
| Prev. close | $145.22 | 52-week low | $48.78 |
| Day low | $144.26 | Volume | 661,500 |
| Day high | $149.49 | Avg. volume | 702,533 |
| 50-day MA | $142.27 | Dividend yield | N/A |
| 200-day MA | $100.03 | Market Cap | 14.96B |
10X GENOMICS, INC. (TXG) Company Bio
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, CNV, ATAC, and Genome and Exome. 10X Genomics was founded by Serge Saxonov, Ben Hindson, Kevin D. Ness and Eduard Diviu Terradas on July 2, 2012 and is headquartered in Pleasanton, CA.
Loading social stream, please wait...